Clinical Trials in Pittsburgh

Showing 14461-14480 of 18,076 trials

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

NCT02228850

The purpose of this study is to evaluate pharmacodynamics (PD) in adult subjects with a diagnosis of Raynaud's Phenomenon secondary to Systemic Sclerosis (SSc).

Raynaud's Phenomenon Secondary to Systemic Sclerosis

NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)35 participantsStarted Nov 2014

Encinitas, California, United States • Ann Arbor, Michigan, United States • Cleveland, Ohio, United States +1 more locations

TERMINATEDPhase 3< 1 mile

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

NCT00580216

The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).

Atrial Fibrillation

Sanofi3,773 participantsStarted Dec 2007

Mobile, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +535 more locations

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Find Trials by Condition in Pittsburgh

Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Randomized Trial of Suicide Gene Therapy and Prostate Cancer

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

Performance of the ePrime System for Cellulite

A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations

APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Elder Surgery - Functional Recovery Following Beta Blockade

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients